The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism

Clinical Endocrinology

Volumn 63, Issue 2, 2005, Pages 203-206

  Ozcan, Omer ^a   Cakir, Erdinc ^a   Yaman, Halil ^a   Akgul, Emin Ozgur ^a   Erturk, Kivilcim ^a   Beyhan, Zeynel ^a   Bilgi, Cumhur ^a   Erbil, Mehmet Kemal ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRITE; THYROXINE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BODY MASS; CARDIOVASCULAR RISK; CHEMICAL ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ARGININE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; ENZYME INHIBITORS; FEMALE; HOMOCYSTEINE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MIDDLE AGED; NITRIC OXIDE; RISK FACTORS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 23244460346     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02326.x     Document Type: Article

References (26)

1. Surks, M.I. & Ocampo, E. (1996) Subclinical thyroid disease. American Journal of Medicine, 100, 217-223.
2. Rivolta, G., Cerutti, R., Colombo, R., Miano, G., Dionisio, P. & Grossi, E. (1999) Prevalence of subclinical hypothyroidism in a population living in the Milan metropolitan area. Journal of Endocrinological Investigation, 22, 693-697.
3. McDermott, M.T. & Ridgway, E.C. (2001) Subclinical hypothyroidism is mild thyroid failure and should be treated. Journal of Clinical Endocrinology and Metabolism, 86, 4585-4590.
4. Hak, A.E., Pols, H.A.P., Visser, T.J., Drexhage, H.E., Hofman, A. & Witteamn, J.C.M. (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Archives of International Medicine, 132, 270-278.
5. Vanderpump, M.P., Turnbridge, W.M., French, J.M., Appleton, D., Bates, D., Clark, F., Grimley Evans, J., Rodgers, H., Turnbridge, F. & Young, E.T. (1996) The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid, 6, 155-160.
6. Vallance, P., Leone, A., Calver, A., Collier, J. & Moncada, S. (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet, 339, 572-575.
7. Austin, M.A., Breslow, J.L., Hennekens, C.H., Buring, J.E., Willet, W.C. & Krauss, R.M. (1988) Low density lipoprotein subclass patterns and risk of myocardial infarction. Journal of the American Medical Association, 260, 1917-1921.
8. Boger, R.H. (2004) Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the 'L-arginine paradox' and acts as a novel cardiovascular risk factor. Journal of Nutrition, 134 (10 Suppl.), 2842S-2847S.
9. Homma, Y. (2004) Predictors of atherosclerosis. Journal of Atherosclererosis and Thrombosis, 11 (5), 265-270.
10. Araki, A. & Sako, Y. (1987) Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. Journal of Chromatograph, 422, 43-52.
11. Hirano, T., Ito, Y., Saegusa, H. & Yoshino, G. (2003) A novel and simple method for quantification of small, dense LDL. Journal of Lipid Research, 44 (11), 2193-2201.
12. G -dimethylarginine in human plasma by high-performance liquid chromatography. Journal of Chromatography B, 2, 467-471.
13. Moshage, H., Kok, B., Huizenga, J.R. & Jansen, P.L. (1995) Nitrite and nitrate determinations in plasma: a critical evaluation. Clinical Chemistry, 41, 892-896.
14. Suwaidi, J.A., Hamasaki, S., Higano, S.T., Nishimura, R.A., Holmes Jr, D.R. & Lerman, A. (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation, 101, 948-954.
15. Schacetylcholineinger, V., Britten, M.B. & Zeiher, A.M. (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation, 101, 1899-1906.
16. Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T. & Munzel, T. (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation, 104, 2673-2678.
17. Taddei, S., Caraccio, N., Virdis, A., Dardano, A., Versari, D., Ghiadoni, L., Salvetti, A., Ferrannini, E. & Monzani, F. (2003) Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. Journal of Clinical Endocrinology and Metabolism, 88 (8), 3731-3737.
18. Ojamaa, K., Klemperer, J.D. & Klein, I. (1996) Acute effects of thyroid hormone on vascular smooth muscle. Thyroid, 6, 505-512.
19. Klemperer, J.D., Klein, I., Gomez, M., Helm, R.E., Ojamaa, K., Thomas, S.J., Isom, O.W. & Krieger, K. (1995) Thyroid hormone treatment after coronary-artery bypass surgery. New England Journal of Medicine, 333, 1522-1527.
20. Hermenegildo, C., Medina, P., Peiró, M., Segarra, G., Vila, J.M., Ortega, J. & Lluch, S. (2002) Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients. Journal of Clinical Endocrinology and Metabolism, 87, 5636-5640.
21. Perez, A., Cubero, J.M., Sucunza, N., Ortega, E., Arcelus, R., Rodriguez-Espinosa, J., Ordonez-Llanos, J. & Blanco-Vaca, F. (2004) Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism. Metabolism, 53 (11), 1512-1515.
22. Luboshitzky, R. & Herer, P. (2004) Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism. Neuro Endocrinology Letters, 25 (4), 262-266.
23. Christ-Grain, M., Meier, C., Guglielmetti, M., Huber, P.R., Riesen, W., Staub, J.J. & Muller, B. (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis, 166 (2), 379-386.
24. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P. & Hennekens, C.H. (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine, 336 (14), 973-979.
25. Ridker, P.M., Hennekens, C.H., Buring, J.E. & Rifai, N. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine, 342 (12), 836-843.
26. Andersen, S., Pedersen, K.M., Bruun, N.H. & Laurberg, P. (2002) Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. Journal of Clinical Endocrinology and Metabolism, 87, 1068-1072.